Our aim was to determine whether seven functional, common polymorphisms in the five genes mediating this metabolic pathway (CYP2J2, CYP2C8, CYP4A11, CYP4F2, and EPHX2) are involved in the incidence of DKD and/or clinical outcomes in these patients. The gene discussed is CYP4A11; the disease is diabetic kidney disease.